SYT7 and myeloid sarcoma: In more detail, the upregulation of miR-432-5p in MS grey matter lesions was identified when compared to white matter lesions, and, along with four other miRNAs, miR-432-5p modulates neuronal structures in MS by targeting synaptotagmin-7 [74].